Abstract:Background: Activated hepatic stellate cells (aHSCs) regulate the function of immune cells during liver fibrosis. As major innate cells in the liver, macrophages have inducible plasticity. Nevertheless, the mechanisms through which aHSCs regulate macrophages' phenotype and function during liver fibrosis and cirrhosis remain unclear. In this study, we examined the immunoregulatory function of aHSCs during liver fibrosis and explored their role in regulating macrophage phenotype and function. Methods: A total of 96 patients with different stages of chronic hepatitis B-related liver fibrosis were recruited in the study. Metavir score system was used to evaluate the degree of fibrosis. The expression of hepatic CCL2 and M2 phenotype macrophage marker CD163 were detected by immunohistochemistry, and the relationship among hepatic CD163, CCL2, and fibrosis scores were also explored. In the in vitro model, the aHSCs isolated from human liver tissues and THP-1-derived M0-type macrophages (M0MΦ) were co-cultured to observe whether and how aHSCs regulate the phenotype and function of macrophages. To explore whether CCL2/CCR2 axis has a crucial role in macrophage phenotypic changes during liver fibrosis, we treated the M0MΦ with recombinant human CCL2 or its specific receptor antagonist INCB-3284. Furthermore, we used LX2 and TGF-β-activated LX2 to mimic the different activation statuses of aHSCs to further confirm our results. Results: In patients, the infiltration of M2 macrophages increased during the progression of liver fibrosis. Intriguingly, as a key molecule for aHSC chemotactic macrophage aggregation, CCL2 markedly up-regulated the expression of CD163 and CD206 on the macrophages, which was further confirmed by adding the CCR2 antagonist (INCB 3284) into the cell culture system. In addition, the TGF-β stimulated LX2 further confirmed that aHSCs up-regulate the expression of CD163 and CD206 on macrophages. LX2 stimulated with TGF-β could produce more CCL2 and up-regulate other M2 phenotype macrophage-specific markers, including IL-10, ARG-1, and CCR2 besides CD163 and CD206 at the gene level, indicating that the different activation status of aHSCs might affect the final phenotype and function of macrophages. Conclusions: The expression of the M2 macrophage marker increases during liver fibrosis progression and is associated with fibrosis severity. AHSCs can recruit macrophages through the CCL2/CCR2 pathway and induce M2 phenotypic transformation.

Role of Macrophage Migration Inhibitory Factor in Hepatic Stellate Cells Activation

HMGB1-induced Autophagy Facilitates Hepatic Stellate Cells Activation: a New Pathway in Liver Fibrosis

[Effect of Antisense Oligonucleotides Targeting Focal Adhesion Kinase on the Proliferation and Activation of Hepatic Stellate Cells].

MicroRNA-146b Regulates Hepatic Stellate Cell Activation Via Targeting of KLF4.

Increased Smad1 expression and transcriptional activity enhances trans-differentiation of hepatic stellate cells.

Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells

Activated Hepatic Stellate Cells Induce Infiltration and Formation of CD163+ Macrophages via CCL2/CCR2 Pathway

CaM/CaMKII mediates activation and proliferation of hepatic stellate cells regulated by ASIC1a

Inhibitory Effect of Human Interferon‐beta‐1a on Activated Rat and Human Hepatic Stellate Cells

Involvement of Mir-30C in Hepatic Stellate Cell Activation Through the Repression of Plasminogen Activator Inhibitor-1.

Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies

Activated Hepatic Stellate Cells Promote the M1 to M2 Macrophage Transformation and Liver Fibrosis by Elevating the Histone Acetylation Level

MiR-22-3p and Mir-29A-3p Synergistically Inhibit Hepatic Stellate Cell Activation by Targeting AKT3

Bioactive Compound Reveals a Novel Function for Ribosomal Protein S5 in Hepatic Stellate Cell Activation and Hepatic Fibrosis.

Activin A plays an essential role in migration and proliferation of hepatic stellate cells via Smad3 and calcium signaling

Regulation of Hepatic Stellate Cell Activation and Proliferation by Hedgehog Signal Pathway

Mir-146B-5p Activation of Hepatic Stellate Cells Contributes to the Progression of Fibrosis by Directly Targeting HIPK1

Effect of RhoA on transforming growth factor β1-induced rat hepatic stellate cell migration.

214 in HSCs is exerted,at least in part,via down-regulating TOM1 expression

Association Of Differentially Expressed Genes With Activation Of Mouse Hepatic Stellate Cells By High-Density Cdna Mircoarray

MircoRNA-145 Promotes Activation of Hepatic Stellate Cells Via Targeting Krüppel-Like Factor 4